Schonfeld Strategic Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.93M | Buy |
77,983
+20,833
| +36% | +$1.32M | 0.03% | 504 |
|
|
2025
Q1 | $3.03M | Sell |
57,150
-2,550
| -4% | -$135K | 0.02% | 652 |
|
|
2024
Q4 | $3.34M | Buy |
59,700
+29,165
| +96% | +$1.63M | 0.02% | 586 |
|
|
2024
Q3 | $1.6M | Buy |
30,535
+19,614
| +180% | +$1.03M | 0.01% | 859 |
|
|
2024
Q2 | $448K | Buy |
+10,921
| New | +$448K | ﹤0.01% | 1400 |
|
|
2023
Q2 | – | Sell |
-13,311
| Closed | -$237K | – | 2274 |
|
|
2023
Q1 | $237K | Sell |
13,311
-107,378
| -89% | -$1.92M | ﹤0.01% | 1434 |
|
|
2022
Q4 | $3.51M | Buy |
120,689
+71,786
| +147% | +$2.09M | 0.03% | 596 |
|
|
2022
Q3 | $1.2M | Buy |
+48,903
| New | +$1.2M | 0.01% | 1146 |
|
|
2018
Q4 | – | Sell |
-47,100
| Closed | -$1.37M | – | 1208 |
|
|
2018
Q3 | $1.37M | Sell |
47,100
-48,900
| -51% | -$1.43M | 0.06% | 368 |
|
|
2018
Q2 | $3M | Buy |
+96,000
| New | +$3M | 0.16% | 207 |
|